- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02932735
The Efficacy of Probe-based Confocal Laser Endomicroscopy in Staging OLGIM
October 12, 2016 updated by: Yanqing Li, Shandong University
Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer.
Precisely surveillance of patients with GIM may result in early detection and improved prognosis.
Though important, it is not necessary to recommend surveillance endoscopy for all patients with GIM, since the progression rate to gastric cancer within 10 years is only 1.8% in those patients.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
30
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Consecutive patients scheduled for pCLE examination will be recruited in this study at Qilu Hospital, Shandong University.
Description
Inclusion Criteria:
- Patients aged 40 years or older with Helicobacter pylori infection;
- Histologically verified GIM, atrophic gastritis or dysplasia.
Exclusion Criteria:
- Patients with gastrectomy, acute GI bleeding and advanced gastric cancer;
- Conditions unsuitable for performance of pCLE, such as coagulopathy, impaired renal function or allergy to fluorescein sodium;
- Pregnancy or breastfeeding;
- Inability to provide informed consent and other situations that could interfere with the examination or therapeutic protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the sensitivity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM).
Time Frame: 6 months
|
6 months
|
|
the of specificity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM).
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the of sensitivity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging Gastric Intestinal Metaplasia (GIM).
Time Frame: 6 months
|
6 months
|
|
the of specificity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging Gastric Intestinal Metaplasia (GIM).
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Anticipated)
June 1, 2017
Study Completion (Anticipated)
June 1, 2017
Study Registration Dates
First Submitted
October 10, 2016
First Submitted That Met QC Criteria
October 12, 2016
First Posted (Estimate)
October 13, 2016
Study Record Updates
Last Update Posted (Estimate)
October 13, 2016
Last Update Submitted That Met QC Criteria
October 12, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016SDU-QILU-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Probe-based Confocal Laser Endomicroscopy
-
Shandong UniversityCompletedUsing Copolamine Butylbromide in Probe-based Confocal Laser Endomicroscopy for Gastroendoscopy ExaminationChina
-
Shandong UniversityUnknownColorectal Polyps | Artificial Intelligence | Probe-based Confocal Laser EndomicroscopyChina
-
Eye & ENT Hospital of Fudan UniversityUnknownLaryngeal Leiomyoma | Probe-based Confocal Laser EndomicroscopyChina
-
Shandong UniversityCompletedArtificial Intelligence | Gastric Diseases | Confocal Laser EndomicroscopyChina
-
Shandong UniversityRecruitingArtificial Intelligence | Intestinal Metaplasia | Confocal Laser EndomicroscopyChina
-
Shandong UniversityRecruitingIntestinal Metaplasia of Gastric Mucosa | Confocal Laser EndomicroscopyChina
-
Shandong UniversityUnknownGastric Intestinal Metaplasia | Confocal Laser Endomicroscopy | Biopsy | Operative Link on Gastric Intestinal MetaplasiaChina
-
Guangzhou Medical UniversityNot yet recruitingConfocal Laser Endomicroscopy | Cryoablation | Lung Cancer (Suspected or Confirmed) | Robotic Bronchoscopy System
-
Shandong UniversityCompletedEsophageal Neoplasms | Artificial Intelligence | Confocal Laser EndomicroscopyChina
-
University of FribourgRecruitingBreast Cancer Surgery | Confocal Laser Endomicroscopy | Breast Cancer Invasive | LumpectomySwitzerland